Affimed N.V. (AFMD)

$0.18 -0.10 (-34.95%)
Market Cap 2.92M
Revenue (ttm) 8.96M
Net Income (ttm) -114.66M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,279.69%
Debt to Equity Ratio 0.47
Volume 23,468,002
Avg Vol 19,511,936
Day's Range N/A - N/A
Shares Out 16.10M
Stochastic %K 15%
Beta 2.07
Analysts Sell
Price Target $6.83

Company Profile

Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States and Germany. The company's lead product candidates include AFM13 that has completed Phase 2 clinical trial for CD30-positive lymphoma, Phase Ib clinical trial for hodgkin lymphoma, and completed Phase IIb clinical study for peripheral T-cell lymphoma; AFM24, a tetravalent, bispecific epidermal growth factor receptor, and CD16A-binding innate cell engager, wh...

Industry: Biotechnology
Sector: Healthcare
Phone: 49 621 560030
Fax: 49 621 56003 649
Address:
Gottlieb-Daimler-Straße 2, Mannheim, Germany
Think_Bigly
Think_Bigly Jun. 27 at 6:27 PM
$AFMD https://www.investing.com/news/company-news/bluebird-bio-acquired-to-scale-gene-therapy-access-93CH-4075656
0 · Reply
Think_Bigly
Think_Bigly Jun. 27 at 6:24 PM
$AFMD is a hero or a zero. Roche deal makes it huge hero from here.. 2-3x BLUE - sold for $4.97 https://www.genengnews.com/news/genentech-affimed-launch-up-to-5b-cancer-immunotherapy-collaboration/
0 · Reply
Think_Bigly
Think_Bigly Jun. 21 at 9:32 PM
$AFMD Who/why the heck did this trade 919M.. 3 days later.. causing price to move up. HUGE volume.. 3 days later?
1 · Reply
Think_Bigly
Think_Bigly Jun. 21 at 9:28 PM
$AFMD filed insolvency 5/13.. dropped to 13.5 cents. Then on 5/16.. 919M shares traded it up to 57 cents.. then down to .27. There were only Shares Short (4/30/2025) - 580.55k or < 4%. Short % of Float (4/30/2025) 3.75% https://finance.yahoo.com/quote/AFMDQ/key-statistics/
0 · Reply
deathknight
deathknight Jun. 20 at 8:04 PM
$AFMD
2 · Reply
deathknight
deathknight Jun. 20 at 8:02 PM
$AFMD According to Chatgpt, Affimed's insolvency lawyers has ample experience in stressed assets M&A. Tobias Wahl is a German attorney and certified specialist in insolvency and restructuring law. While his core expertise lies in insolvency administration and restructuring, he has also been involved in M&A transactions arising from insolvency proceedings, which can include biotech and other sectors depending on the case. For example, he served as the preliminary insolvency administrator for Forward AM, a company in the 3D printing materials space, where he worked on stabilizing operations and preparing for potential acquisition or restructuring. He has also written about corporate acquisitions from insolvency, highlighting legal frameworks and practical considerations in distressed M&A scenarios.
1 · Reply
Think_Bigly
Think_Bigly Jun. 20 at 6:44 PM
$AFMD One further discount Roche gains since announcing the partner package: A 1/10 reverse split. So the $18, is actually $1.80 at the original share structure. Amazing value creation goes to Roche.
0 · Reply
Think_Bigly
Think_Bigly Jun. 20 at 5:36 PM
$AFMD Roche can eliminate 90% of partner payments, ALL future royalties and avoid disruption of their trials at $18/share. Do the math.
0 · Reply
iamMoab
iamMoab Jun. 20 at 4:56 PM
$AFMD 😏👍
0 · Reply
Omarhabibeh
Omarhabibeh Jun. 20 at 1:07 PM
$AFMD Reactivating the website is definitely good news. It means they found funding. For us current shareholders, though, a buyout is the only solution. Other options will definitely wipe us out.🤞
0 · Reply
Latest News on AFMD
No data available.
Think_Bigly
Think_Bigly Jun. 27 at 6:27 PM
$AFMD https://www.investing.com/news/company-news/bluebird-bio-acquired-to-scale-gene-therapy-access-93CH-4075656
0 · Reply
Think_Bigly
Think_Bigly Jun. 27 at 6:24 PM
$AFMD is a hero or a zero. Roche deal makes it huge hero from here.. 2-3x BLUE - sold for $4.97 https://www.genengnews.com/news/genentech-affimed-launch-up-to-5b-cancer-immunotherapy-collaboration/
0 · Reply
Think_Bigly
Think_Bigly Jun. 21 at 9:32 PM
$AFMD Who/why the heck did this trade 919M.. 3 days later.. causing price to move up. HUGE volume.. 3 days later?
1 · Reply
Think_Bigly
Think_Bigly Jun. 21 at 9:28 PM
$AFMD filed insolvency 5/13.. dropped to 13.5 cents. Then on 5/16.. 919M shares traded it up to 57 cents.. then down to .27. There were only Shares Short (4/30/2025) - 580.55k or < 4%. Short % of Float (4/30/2025) 3.75% https://finance.yahoo.com/quote/AFMDQ/key-statistics/
0 · Reply
deathknight
deathknight Jun. 20 at 8:04 PM
$AFMD
2 · Reply
deathknight
deathknight Jun. 20 at 8:02 PM
$AFMD According to Chatgpt, Affimed's insolvency lawyers has ample experience in stressed assets M&A. Tobias Wahl is a German attorney and certified specialist in insolvency and restructuring law. While his core expertise lies in insolvency administration and restructuring, he has also been involved in M&A transactions arising from insolvency proceedings, which can include biotech and other sectors depending on the case. For example, he served as the preliminary insolvency administrator for Forward AM, a company in the 3D printing materials space, where he worked on stabilizing operations and preparing for potential acquisition or restructuring. He has also written about corporate acquisitions from insolvency, highlighting legal frameworks and practical considerations in distressed M&A scenarios.
1 · Reply
Think_Bigly
Think_Bigly Jun. 20 at 6:44 PM
$AFMD One further discount Roche gains since announcing the partner package: A 1/10 reverse split. So the $18, is actually $1.80 at the original share structure. Amazing value creation goes to Roche.
0 · Reply
Think_Bigly
Think_Bigly Jun. 20 at 5:36 PM
$AFMD Roche can eliminate 90% of partner payments, ALL future royalties and avoid disruption of their trials at $18/share. Do the math.
0 · Reply
iamMoab
iamMoab Jun. 20 at 4:56 PM
$AFMD 😏👍
0 · Reply
Omarhabibeh
Omarhabibeh Jun. 20 at 1:07 PM
$AFMD Reactivating the website is definitely good news. It means they found funding. For us current shareholders, though, a buyout is the only solution. Other options will definitely wipe us out.🤞
0 · Reply
Omarhabibeh
Omarhabibeh Jun. 19 at 1:40 PM
$AFMD https://www.affimed.com active again 🤔
1 · Reply
deathknight
deathknight Jun. 19 at 12:45 PM
$AFMD anyone noticed that their website has quietly come back online? I can't find any updates been made. So it could be a vetting process and seems they have passed that .
2 · Reply
Think_Bigly
Think_Bigly Jun. 17 at 4:39 PM
$AFMD at this point, it would cost Roche more to disengage the trials they've been running for 4-5 years and let some else have the data than it would to buy it.
0 · Reply
Think_Bigly
Think_Bigly Jun. 17 at 4:05 PM
$AFMD any day..
1 · Reply
Morseus01
Morseus01 Jun. 16 at 8:45 PM
$AFMD what’s up with the chart here this wasn’t at .2 today 😂😂😂
0 · Reply
Think_Bigly
Think_Bigly Jun. 7 at 7:40 PM
$AFMD BLUE cashed out at $5 after similar predicament. Affi should do better with Roche funding and running trials... target price for bluebird bio Inc (BLUE, Financial) is $8.67 with a high estimate of $10.00 and a low estimate of $8.00. https://www.gurufocus.com/news/2901598/bluebird-bio-blue-acquired-by-carlyle-and-sk-capital-partners-blue-stock-news
1 · Reply
norbertm
norbertm Jun. 7 at 2:23 AM
$AFMD I don't own this but most recent posting here are just misleading: this company was delisted by NASDAQ as it applied for insolvancy in Germany a month ago. https://www.globenewswire.com/news-release/2025/05/13/3080104/0/en/Affimed-Announces-Filing-for-the-Opening-of-Insolvency-Proceedings.html
2 · Reply
Think_Bigly
Think_Bigly Jun. 6 at 6:04 PM
$AFMD Affimed has industry-leading assets and a platform primed to generate novel molecules, allowing it to further deepen its pipeline and creating partnering opportunities. With its validated platform, Affimed is the most advanced company in the field, which has enabled deals with Merck and Roche’s Genentech. https://www.nature.com/articles/d43747-020-00858-y
0 · Reply
Think_Bigly
Think_Bigly Jun. 5 at 5:44 PM
$AFMD remember.. some one's thought this is worth $148/share. And Roche, still engaged, thought $4.9B in partner payments.. +++ ongoing royalties. https://www.biospace.com/affimed-stock-more-than-doubles-after-4-9-billion-deal-with-roche
0 · Reply
deathknight
deathknight Jun. 5 at 1:56 AM
$AFMD ok, now their website is 404, instead of 403 (forbidden to access). Seems the whole site has been removed/deleted. Likely they first restricted access to backup or transfer data and then deleted the website. Something is definitely happening.
2 · Reply
Morseus01
Morseus01 Jun. 4 at 7:44 PM
$AFMD the collaboration with Roche green tech is still ongoing hopefully that means there’s a chance that this can atleast bounce back some at some point people are still accumulating most likely dca
0 · Reply
Think_Bigly
Think_Bigly Jun. 3 at 7:51 PM
$AFMD Roche can eliminate 90% of partner payments and all future royalties while avoiding disruption of their trials at $ 18 share
0 · Reply